Giant Biogene Holding Co Ltd (HKSE:02367) Share Price

Company Profile

Business description
Giant Biogene Holding Co Ltd design, develop and manufacture professional skin treatment products with recombinant collagen as the key bioactive ingredient. The company also develops and manufactures rare ginsenosides technology-based functional foods. The company utilizes proprietary synthetic biology technology to develop and manufacture multiple types of recombinant collagen and rare ginsenosides in-house. Bioactive ingredients offer a wealth of beauty and health properties such as skin repair, anti-aging, whitening, moisturizing and immunity improvement with a broad range of applications in the beauty and health sectors.
Contact
No. 1855, Shanglin Yuan 7th Road
Chang’an District
Shaanxi Province
Xi’an
CHN
http://www.xajuzi.com
Sector
Consumer Defensive
Stock type
Defensive
Industry
Household & Personal Products
Fiscal Year End
31 December 2025
Employees
2,162

Recommended

We see faster cloud growth and improved longer-term profitability for Alphabet.

Malik Ahmed Khan, CFA | 25 October 2025

Solid start to 2026 but shares overvalued.

Jon Mills, CFA | 24 October 2025

With recent structural changes and strong Azure performance, here’s what we think of Microsoft stock.

Dan Romanoff, CPA | 23 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,317.20	26.50	-0.28%
CAC 40	8,225.63	0.15	-0.00%
DAX 40	24,239.89	32.10	0.13%
Dow JONES (US)	47,207.12	472.51	1.01%
FTSE 100	9,645.62	67.05	0.70%
HKSE	26,160.15	192.17	0.74%
NASDAQ	23,204.87	263.07	1.15%
Nikkei 225	49,299.65	658.04	1.35%
NZX 50 Index	13,391.59	14.49	0.11%
S&P 500	6,791.69	53.25	0.79%
S&P/ASX 200	9,019.00	25.20	-0.28%
SSE Composite Index	3,950.31	27.90	0.71%